Tue, May 21, 2024
Mon, May 20, 2024
Fri, May 17, 2024
Thu, May 16, 2024

Leland Gershell Initiated (CAPR) at Buy and Held Target at $14 on, May 17th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-14-on-may-17th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Initiated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $14 on, May 17th, 2024.

Leland has made no other calls on CAPR in the last 4 months.



There are 3 other peers that have a rating on CAPR. Out of the 3 peers that are also analyzing CAPR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Aydin Huseynov of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, May 14th, 2024
  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, May 14th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Tuesday, May 14th, 2024

Publication Contributing Sources